• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

ADA/EASD Calls for Wide Systemic Change to Address Impact of Social Determinants of Health

Video

“Social determinants of health are barriers to high-quality care…and we can’t ignore these anymore and expect for diabetes care to improve.”

Nisa Maruthur, MD, MHS, is a primary care physician and associate professor of medicine at Johns Hopkins University,with a deep commitment to research aimed at improving community-based diabetes prevention. As a member of the writing committee for the the new American Diabetes Association/ European Association for the Study of Diabetes consensus report on management of hyperglycemia in type 2 diabetes, she highlighted for Patient Care® the need for systemic and institutional change called for in the consensus report.


For more conversations with Dr Maruthur:

ADA, EASD 2022 Consensus Report from the Primary Care Point of View, with Nisa Maruthur, MD, MHS

Primary Care Would Benefit from Education on Use of SGLT-2 Inhibitors, GLP-1 Mimetics: Nisa Maruthur, MD, MHS


Nisa M Maruthur, MD, MHS, is associate professor of medicine, epidemiology, and nursing at Johns Hopkins University and director of the general internal medicine fellowship program, at Johns Hopkins Medicine, in Baltimore, MD. Dr Maruthur also conducts clinical research in diabetes with a focus on diabetes prevention. She is particularly interetsetd in community-based approaches to improving diabetes outcomes and in individualized medicine.


Related Videos
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Document COVID Sequelae and Primary Care: An Interview with Samoon Ahmad, MD
© 2024 MJH Life Sciences

All rights reserved.